Search clinical trials for: Neo adjuvant chemotherapy

Total 127544 results

Huazhong University of Science and Technology
Shandong University; Zhejiang University

Completed

A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients (CC-01)

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

China
Walter and Eliza Hall Institute of Medical Research
Johns Hopkins University

Active, not recruiting

Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

Ovarian Cancer

Australia, United States
Rigshospitalet, Denmark
Novo Nordisk A/S; Copenhagen University Hospital at Herlev; Danish Cancer Society and other collaborators

Completed

Pedometer Intervention and Health Effects for Sedentary Colorectal Cancer Patients During Adjuvant Chemotherapy

Colorectal Cancer

Denmark
Cancer Trials Ireland

Terminated

Plasma Biomarkers C-RAC, ICORG 12-27, V1

Colorectal Cancer

Ireland
Spanish Breast Cancer Research Group
Sanofi

Completed

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Breast Neoplasms

Spain
Spanish Breast Cancer Research Group
Hoffmann-La Roche; IBEROAMERICAN COALITION FOR BREAST ONCOLOGY RESEARCH (CIBOMA)

Completed

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Breast Cancer

Spain
Spanish Breast Cancer Research Group
Sanofi; Pfizer; Hoffmann-La Roche

Completed

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Breast Cancer

Spain
Necmettin Erbakan University

Completed

The Effect of Virtual Reality on Anxiety and Fatigue in Women With Breast Cancer Receiving Adjuvant Chemotherapy

Fatigue | Anxiety | Breast Cancer Female

Turkey
Ottawa Hospital Research Institute

Active, not recruiting

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Early-stage Breast Cancer

Canada
Northwell Health

Withdrawn

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Uterine Carcinoma

United States
Hoffmann-La Roche

Completed

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Triple-Negative Breast Cancer

United States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
Yu jiren

Active, not recruiting

Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)

Gastric Cancer Stage III

China
Spanish Breast Cancer Research Group
Merck Sharp & Dohme LLC

Completed

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Breast Cancer

Spain
Borstkanker Onderzoek Groep
Roche Pharma AG; BOOG Study Center

Active, not recruiting

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (TRAIN-3)

Breast Cancer

Netherlands
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma

Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Indolent Adult Non-Hodgkin Lymphoma

United States
Yuhong Li

Completed

Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

Pancreatic Cancer Resectable

China
University of Maryland, Baltimore

Terminated

Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme (GCC 1224)

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)

United States
Dr Kundan Singh Chufal

Active, not recruiting

Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning (QARC)

Esophageal Neoplasm

Australia, India
Institut Claudius Regaud

Completed

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC (MIMOSA)

Triple Negative Breast Cancer

France
Centre Henri Becquerel

Completed

Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer (QUALITY-AGE)

Breast Cancer

France
Kyungpook National University Hospital

Active, not recruiting

Early Commencement of Adjuvant Chemotherapy for Colon Cancer (ECTX)

Colon Cancer

Korea, Republic of
University Hospital, Montpellier

Withdrawn

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol (LIDA-ADJ)

Hepatocellular Carcinoma

France
Asan Medical Center
Seoul St. Mary's Hospital; Severance Hospital; Bundang CHA Hospital

Completed

Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma

Cholangiocarcinoma | Biliary Tract Cancer | Adjuvant Chemotherapy | Capecitabine | Gemcitabine | Cisplatin

Korea, Republic of
Gritstone bio, Inc.

Terminated

Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer

Colorectal Neoplasms | Colonic Neoplasms

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Negative

United States
NSABP Foundation Inc
Novartis Pharmaceuticals; Natera, Inc.

Withdrawn

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Colon Cancer

United States
The Netherlands Cancer Institute

Active, not recruiting

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (neo-TN)

Breast Cancer

Netherlands
Royal Marsden NHS Foundation Trust
Merck KGaA, Darmstadt, Germany; University of Oxford; University of Surrey

Terminated

Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer (POLEM)

Microsatellite Instability | Stage III Colon Cancer | POLE Exonuclease Mutant Colon Cancer

United Kingdom
Michael Bau Mortensen

Completed

Adjuvant PIPAC in Gastric Cancer Patients (PIPAC-OPC4)

Gastric Cancer | Gastric Adenocarcinoma

Sweden, Denmark
St. Olavs Hospital
Ullevaal University Hospital; Asker & Baerum Hospital; Haukeland University Hospital and other collaborators

Active, not recruiting

Physically Active During Cancer Treatment (FAKT) (FAKT)

Neoplasms, Colorectal

Norway
Ospedale Umberto I di Torino
Rete Oncologica Piemonte, Valle d'Aosta

Terminated

The Stoma Closure Before or After Adjuvant Therapy Trial (STOMAD)

Rectal Cancer | Ileostomy

Italy
Sulai Liu

Active, not recruiting

Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection

Hepatocellular Carcinoma

China
Institut Curie
Servier; UNICANCER

Completed

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma (FOTEADJ)

Uveal Melanoma

France, Switzerland
Zhao Chong
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi... and other collaborators

Completed

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Local Advanced High Risk Nasopharyngeal Carcinoma

China
Lawson Health Research Institute
The Ottawa Hospital

Completed

A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer

Breast Neoplasms

Canada
Affiliated Hospital of Qinghai University
LanZhou University; Qinghai People's Hospital

Completed

The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation

Gastric Cancer

China
Xiaohua Wu MD

Active, not recruiting

Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer (ACTS)

Ovarian Cancer

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Bladder Cancer

United States, Canada
Hoffmann-La Roche

Completed

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Breast Cancer

United States, France, Czechia, Italy, Korea, Republic of, Australia, Belgium, Brazil, Canada, Germany, Guatemala, Hong Kong, Hungary, Panama, Peru, Poland, Spain, Taiwan, United Kingdom, Colombia, Bosnia and Herzegovina, Chile, El... and more
Fudan University
Changhai Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaborators

Completed

New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases

Neoplasm Metastasis | Liver Neoplasms | Colorectal Neoplasms | Chemotherapy; Maternal, Affecting Fetus

China
Spanish Lung Cancer Group

Completed

Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer (NATCH)

Non-Small-Cell Lung Cancer
Austrian Breast & Colorectal Cancer Study Group

Completed

Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma

Colorectal Carcinoma

Austria
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Second Affiliated... and other collaborators

Terminated

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

Colon Cancer

China
xie congying

Completed

Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma

Gastric Cancer

China
Institut Cancerologie de l'Ouest

Completed

Interest of Touch-massage in Hospital Day Care (TOMAS)

Breast Neoplasm Malignant Female

France
NSABP Foundation Inc
Bayer

Terminated

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer (ARGO)

Stage III (IIIB or IIIC) Colon Cancer

United States
Memorial Sloan Kettering Cancer Center
Pediatric Brain Tumor Consortium

Terminated

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

Fanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)

United States
Sun Yat-sen University

Completed

Improve the Treatment of Thoracic Esophageal Cancer

Thoracic Esophageal Squamous Cell Carcinoma

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
The Skip Viragh Foundation

Active, not recruiting

Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
Zhejiang University

Completed

S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer

Pancreatic Cancer

China

Search clinical trials for: Neo adjuvant chemotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations